1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Hormone Antagonist: new trials by email Literature Review of Hormone Antagonist trials Research Report on Hormone Antagonist
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Durvalumab and Endocrine Therapy in ER+/Her2- Breast Cancer After CD8+ Infiltration Effective Immune-Attractant Exposure Immune-attractant, Durvalumab, Biopsy - Breast Cancer, Estrogen Receptor Positive Tumor | Phase 2 | Completed | UNICANCER | 61 | 2017-02-15 | 2020-09-30 |
Breast Neoplasms (1)
Breast Diseases (1) · Neoplasms (1) · Neoplasms by Site (1) · Skin Diseases (1) · Skin and Connective Tissue Diseases (1)
Biopsy (1) · durvalumab (1) · tremelimumab (1)
UNICANCER (1)
France (1) · Spain (1) · Sweden (1)
2016 (1)